PROGNOSTIC VALUE OF CELLULAR PROLIFERATION AND HISTOLOGIC GRADE IN FOLLICULAR LYMPHOMA

被引:139
作者
MARTIN, AR
WEISENBURGER, DD
CHAN, VC
RUBY, EI
ANDERSON, JR
VOSE, JM
BIERMAN, PJ
BAST, MA
DALEY, DT
ARMITAGE, JO
机构
[1] UNIV NEBRASKA, MED CTR, DEPT PATHOL & MICROBIOL, OMAHA, NE 68198 USA
[2] UNIV NEBRASKA, MED CTR, DEPT PREVENT & SOC MED, OMAHA, NE 68198 USA
[3] UNIV NEBRASKA, MED CTR, DEPT INTERNAL MED, OMAHA, NE 68198 USA
关键词
D O I
10.1182/blood.V85.12.3671.bloodjournal85123671
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical usefulness of histologic grading in follicular lymphoma (FL) is controversial and is further compromised by the subjective nature and poor reproducibility of most systems in current use. Therefore, we decided to objectively evaluate the importance of cellular proliferation in FL, along with the current grading systems. We studied 106 patients with FL who were uniformly staged and aggressively treated. A proliferative index (PI) was determined quantitatively using an automated image analyzer and a new Ki-67 antibody that stains archival paraffin tissues. The cases were also subclassified according to the Berard, Rappaport, Luke-Collins, and Jaffe methods, and survival analysis was performed. Patients with a low PI (<40%) had a significantly longer overall survival (OS) than those with a high PI (greater than or equal to 40%). but the PI did not predict failure-free survival (FFS). The mean PI correlated well with the subgroups in each of the various classifications. All four of the classification methods were predictive of OS, but only the Berard method appeared to predict FFS and suggest that a proportion of patients with FL may be curable. In multivariate analysis. histologic classification was the only independent predictor of OS (Berard method: relative risk, 3.1) and the International Prognostic Index was the only independent predictor of FFS (relative risk, 2.3). We conclude that the Berard method for grading of FL is clinically useful and, along with the International Prognostic Index, should be included in future clinical studies of FL. The measurement of cellular proliferation does not appear to add additional useful information in FL. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:3671 / 3678
页数:8
相关论文
共 61 条
[21]  
2-9
[22]   PROGNOSTIC INDICATORS IN CENTROBLASTIC-CENTROCYTIC LYMPHOMA [J].
GRIFFIN, NR ;
HOWARD, MR ;
QUIRKE, P ;
OBRIEN, CJ ;
CHILD, JA ;
BIRD, CC .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (08) :866-870
[23]  
GROGAN TM, 1988, BLOOD, V71, P1157
[24]   THE PROGNOSTIC VALUE OF KI67 IMMUNOSTAINING IN NON-HODGKINS LYMPHOMA [J].
HALL, PA ;
RICHARDS, MA ;
GREGORY, WM ;
DARDENNE, AJ ;
LISTER, TA ;
STANSFELD, AG .
JOURNAL OF PATHOLOGY, 1988, 154 (03) :223-235
[25]   KI67 AND 4F2 ANTIGEN EXPRESSION AS WELL AS DNA-SYNTHESIS PREDICT SURVIVAL AT RELAPSE TUMOR PROGRESSION IN LOW-GRADE B-CELL LYMPHOMA [J].
HOLTE, H ;
DAVIES, CD ;
BEISKE, K ;
STOKKE, T ;
MARTON, PF ;
SMELAND, EB ;
HOIE, J ;
KVALOY, S .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (06) :975-980
[26]  
HORNING SJ, 1987, CANCER, V59, P1470, DOI 10.1002/1097-0142(19870415)59:8<1470::AID-CNCR2820590813>3.0.CO
[27]  
2-K
[28]   RELEVANCE OF KI-67 EXPRESSION IN THE CLASSIFICATION OF NON-HODGKINS-LYMPHOMAS - A MORPHOMETRIC AND DOUBLE-IMMUNOSTAINING STUDY [J].
HOUMAND, A ;
ABRAHAMSEN, B ;
PEDERSEN, NT .
HISTOPATHOLOGY, 1992, 20 (01) :13-20
[29]  
JAFFE ES, 1993, SEMIN ONCOL, V20, P3
[30]   FOLLICULAR LARGE CELL LYMPHOMA - ANALYSIS AND PROGNOSTIC FACTORS IN 62 PATIENTS [J].
KANTARJIAN, HM ;
MCLAUGHLIN, P ;
FULLER, LM ;
DIXON, DO ;
OSBORNE, BM ;
CABANILLAS, FF .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :811-819